Cargando…

Prediabetes screening: Questionable benefits in the golden years

Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsilingiris, Dimitrios, Vallianou, Natalia G., Dalamaga, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065303/
https://www.ncbi.nlm.nih.gov/pubmed/33912821
http://dx.doi.org/10.1016/j.metop.2021.100091
_version_ 1783682311329415168
author Tsilingiris, Dimitrios
Vallianou, Natalia G.
Dalamaga, Maria
author_facet Tsilingiris, Dimitrios
Vallianou, Natalia G.
Dalamaga, Maria
author_sort Tsilingiris, Dimitrios
collection PubMed
description Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage primarily aim to hinder the development of overt hyperglycemia rather than to prevent complications. Current recommendations for prediabetes testing are common across all adult age categories. Recent evidence arising from the prospective investigation of the natural course of prediabetes among elderly individuals pose questions regarding the benefits of meticulous prediabetes screening in this age group. In view of this and due to the lack of sufficient data to concretely support a positive impact of further preventive strategies among older individuals, screening recommendations should be reevaluated to target selected elderly individuals who are most likely to benefit in terms of quality of life and prognosis. Further therapeutic measures should be tailored to the inherent features of this frail age group, in order to exert a meaningful effect on overall health status.
format Online
Article
Text
id pubmed-8065303
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80653032021-04-27 Prediabetes screening: Questionable benefits in the golden years Tsilingiris, Dimitrios Vallianou, Natalia G. Dalamaga, Maria Metabol Open Editorial Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage primarily aim to hinder the development of overt hyperglycemia rather than to prevent complications. Current recommendations for prediabetes testing are common across all adult age categories. Recent evidence arising from the prospective investigation of the natural course of prediabetes among elderly individuals pose questions regarding the benefits of meticulous prediabetes screening in this age group. In view of this and due to the lack of sufficient data to concretely support a positive impact of further preventive strategies among older individuals, screening recommendations should be reevaluated to target selected elderly individuals who are most likely to benefit in terms of quality of life and prognosis. Further therapeutic measures should be tailored to the inherent features of this frail age group, in order to exert a meaningful effect on overall health status. Elsevier 2021-04-07 /pmc/articles/PMC8065303/ /pubmed/33912821 http://dx.doi.org/10.1016/j.metop.2021.100091 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Tsilingiris, Dimitrios
Vallianou, Natalia G.
Dalamaga, Maria
Prediabetes screening: Questionable benefits in the golden years
title Prediabetes screening: Questionable benefits in the golden years
title_full Prediabetes screening: Questionable benefits in the golden years
title_fullStr Prediabetes screening: Questionable benefits in the golden years
title_full_unstemmed Prediabetes screening: Questionable benefits in the golden years
title_short Prediabetes screening: Questionable benefits in the golden years
title_sort prediabetes screening: questionable benefits in the golden years
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065303/
https://www.ncbi.nlm.nih.gov/pubmed/33912821
http://dx.doi.org/10.1016/j.metop.2021.100091
work_keys_str_mv AT tsilingirisdimitrios prediabetesscreeningquestionablebenefitsinthegoldenyears
AT vallianounataliag prediabetesscreeningquestionablebenefitsinthegoldenyears
AT dalamagamaria prediabetesscreeningquestionablebenefitsinthegoldenyears